Acadian Asset Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,761
| Closed | -$28K | – | 2079 |
|
|
2024
Q3 | $28K | Buy |
+1,761
| New | +$28K | ﹤0.01% | 1929 |
|
|
2023
Q2 | – | Sell |
-50,308
| Closed | -$2.1M | – | 1885 |
|
|
2023
Q1 | $2.1M | Sell |
50,308
-5,343
| -10% | -$223K | 0.01% | 697 |
|
|
2022
Q4 | $1.89M | Buy |
55,651
+11,110
| +25% | +$377K | 0.01% | 692 |
|
|
2022
Q3 | $2.19M | Buy |
44,541
+8,264
| +23% | +$406K | 0.01% | 613 |
|
|
2022
Q2 | $1.43M | Buy |
36,277
+30,213
| +498% | +$1.19M | 0.01% | 729 |
|
|
2022
Q1 | $222K | Sell |
6,064
-13,030
| -68% | -$477K | ﹤0.01% | 1189 |
|
|
2021
Q4 | $1.87M | Sell |
19,094
-8,207
| -30% | -$802K | 0.01% | 674 |
|
|
2021
Q3 | $3.41M | Buy |
27,301
+5,703
| +26% | +$711K | 0.01% | 542 |
|
|
2021
Q2 | $2.71M | Buy |
21,598
+9,330
| +76% | +$1.17M | 0.01% | 627 |
|
|
2021
Q1 | $1.67M | Buy |
+12,268
| New | +$1.67M | 0.01% | 790 |
|
|
2020
Q3 | – | Sell |
-307
| Closed | -$26K | – | 2325 |
|
|
2020
Q2 | $26K | Buy |
+307
| New | +$26K | ﹤0.01% | 2081 |
|
|
2019
Q3 | – | Sell |
-584
| Closed | -$31K | – | 1983 |
|
|
2019
Q2 | $31K | Buy |
+584
| New | +$31K | ﹤0.01% | 1551 |
|